Podcast - Better Science, Better Health: BIA’s CEO is the hardest working man in biotech since Brexit In this podcast, Steve Bates, the UK BioIndustry Association's CEO, discusses both the challenges and opportunities of Brexit on the UK’s biotechnology sector, and the need for strong, vital IP supported by private investment.Steve was an advisor to [...]
Podcast - Better Science, Better Health: The US Chamber's Patrick Kilbride on the Rapidly Changing IP World Patrick Kilbride is vice president of international intellectual property for the Global Innovation Policy Center (GIPC) at the U.S. Chamber of Commerce. Over the last several years, there has been a growing chorus of voices [...]
Podcast - Better Science, Better Health: Stirring the IP Pot Emil Pot was one of the founders of ActoGeniX, which was successfully acquired in 2015 by Intrexon. Emil outlines the ingredients Europe needs to build a company from scratch, and leverage home-grown Intellectual Property.
Press Room From: Morning Health Care Europe <morninghealth@politico.eu> Date: Fri, 5 Oct 2018 at 06:57 Subject: POLITICO Pro Morning Health Care: After Austria comes Romania — Cancer research cash To: POLITICO Europe Subscribers https://www.politico.eu/pro/politico-pro-morning-health-care-after-austria-comes-romania-cancer-research-cash-trans-fats/?utm_source=POLITICO.EU&utm_campaign=0abbd30995-EMAIL_CAMPAIGN_2018_10_04_08_23&utm_medium=email&utm_term=0_10959edeb5-0abbd30995-189777477 RESEARCH — DOES COMMISSION FUNDING MATTER? A study presented Thursday at Gastein made the argument that private funding correlates [...]
Podcast - Better Science, Better Health: VIB’s Johan Cardoen, An EU Biotech Success Story For the first podcast in our series investigating the impact and importance of IP on European biotech and innovation, we have an in-depth discussion with Johan Cardoen of VIB, Gent’s life sciences research institute in Belgium. VIB has been called by Reuters, “part [...]
4 October, 7.30-8.45 CET, Bad Hofgastein
This breakfast session will offer an open debate on the role of IP in EU healthcare innovation, focused on the appropriate role and balance for both public funding and private investments, supported by new research on EU biotech success factors produced by Vital Transformation. Speakers will discuss in a pro-con format whether IP is a problem or a solution to our healthcare needs, and what role the EU will play in supporting next-generation health technologies to promote a sustainable R&D infrastructure in Europe.
EMIF: E-managing the Future of Health Data 16th-17th March 2015, Budapest Pictures An overview 16th March 2016 - Conference Dinner with keynote speech by Sarah Garner Click to view all pictures 17th March 2016 - Full Day Conference at Gerbeaud House Click to view all [...]
EMIF: E-managing the Future of Health Data 16th-17th March 2016, Budapest Speakers Richard Bergstrom, Director General, EFPIA Miklós Bacskai, Chief Strategy & Business Development Officer, Healthware Alison Bourke, Scientific Director, Real World Evidence, IMS Health Iain Buchan, Clinical Professor Public [...]
About EMIF For more information about EMIF, visit the EMIF website Thought Leader Interview: Bart Vannieuwenhuyse, Senior Director Health Information Sciences, Janssen Pharmaceutica; Coordinator EMIF Click here to read the article “When it comes to sharing health data, solving the technical solutions of data sharing is more straightforward [...]
EMIF: E-managing the Future of Health Data 16th-17th March 2015, Budapest Venues 16th March - Kempinski Hotel Corvinus Budapest Erzsébet tér 7-8, 1051 Budapest If you need a hotel room, please book via the official hotel website. http://www.kempinski.com/en/budapest/hotel-corvinus/welcome/ 17th March - Gerbeaud House 1051 Budapest [...]